Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility

  • de la Fuente-Vivas, Dalia
  • Cappitelli, Vincenzo
  • García-Gómez, Rocío
  • Valero-Díaz, Sara
  • Amato, Camilla
  • Rodriguéz, Javier
  • Duro Sánchez, Santiago|||0000-0002-3829-7562
  • von Kriegsheim, Alexander
  • Grusch, Michael|||0000-0001-5486-9340
  • Lozano, José
  • Arribas, Joaquín V|||0000-0002-0504-0664
  • Casar, Berta|||0000-0002-3058-5631
  • Crespo, Piero|||0000-0003-2825-7783
ERK1/2 mitogen-activated protein kinases (ERK) are key regulators of basic cellular processes, including proliferation, survival, and migration. Upon phosphorylation, ERK becomes activated and a portion of it dimerizes. The importance of ERK activation in specific cellular events is generally well documented, but the role played by dimerization is largely unknown. Here, we demonstrate that impeding ERK dimerization precludes cellular movement by interfering with the molecular machinery that executes the rearrangements of the actin cytoskeleton. We also show that a constitutively dimeric ERK mutant can drive cell motility per se, demonstrating that ERK dimerization is both necessary and sufficient for inducing cellular migration. Importantly, we unveil that the scaffold protein kinase suppressor of Ras 1 (KSR1) is a critical element for endowing external agonists, acting through tyrosine kinase receptors, with the capacity to induce ERK dimerization and, subsequently, to unleash cellular motion. In agreement, clinical data disclose that high KSR1 expression levels correlate with greater metastatic potential and adverse evolution of mammary tumors. Overall, our results portray both ERK dimerization and KSR1 as essential factors for the regulation of cell motility and mammary tumor dissemination. In mammary tumor cells, ERK dimerization is both necessary and sufficient for inducing cellular migration. The scaffold protein KSR1 is a critical element for endowing external agonists, acting through tyrosine kinase receptors, with the capacity to induce ERK dimerization and, subsequently, unleashing cellular motion, as a consequence of which tumor cell migration and metastatic dissemination are promoted.
Repisalud
Publicación Artículo científico (JournalArticle)

Isolation and characterization of myogenic precursor cells from human cremaster muscle

  • Naldaiz-Gastesi, Neia
  • Goicoechea, María
  • Aragón, Isabel Maria
  • Pérez-López, Virginia
  • Fuertes-Alvarez, Sandra
  • Herrera-Imbroda, Bernardo
  • López de Munain, Adolfo
  • de Luna-Diaz, Resi
  • Baptista, Pedro M
  • Fernández, M Alejandro
  • Lara, María Fernanda
  • Izeta, Ander
Human myogenic precursor cells have been isolated and expanded from a number of skeletal muscles, but alternative donor biopsy sites must be sought after in diseases where muscle damage is widespread. Biopsy sites must be relatively accessible, and the biopsied muscle dispensable. Here, we aimed to histologically characterize the cremaster muscle with regard number of satellite cells and regenerative fibres, and to isolate and characterize human cremaster muscle-derived stem/precursor cells in adult male donors with the objective of characterizing this muscle as a novel source of myogenic precursor cells. Cremaster muscle biopsies (or adjacent non-muscle tissue for negative controls; N = 19) were taken from male patients undergoing routine surgery for urogenital pathology. Myosphere cultures were derived and tested for their in vitro and in vivo myogenic differentiation and muscle regeneration capacities. Cremaster-derived myogenic precursor cells were maintained by myosphere culture and efficiently differentiated to myotubes in adhesion culture. Upon transplantation to an immunocompromised mouse model of cardiotoxin-induced acute muscle damage, human cremaster-derived myogenic precursor cells survived to the transplants and contributed to muscle regeneration. These precursors are a good candidate for cell therapy approaches of skeletal muscle. Due to their location and developmental origin, we propose that they might be best suited for regeneration of the rhabdosphincter in patients undergoing stress urinary incontinence after radical prostatectomy.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Reference database and performance evaluation of methods for extraction of atrial fibrillatory waves in the ECG

  • Alcaraz, Raul
  • SORNMO, LEIF
  • Rieta, J J|||0000-0002-3364-6380
[EN] Objective: This study proposes a reference database, composed of a large number of simulated ECG signals in atrial fibrillation (AF), for investigating the performance of methods for extraction of atrial fibrillatory waves (f -waves). Approach: The simulated signals are produced using a recently published and validated model of 12-lead ECGs in AF. The database is composed of eight signal sets together accounting for a wide range of characteristics known to represent major challenges in f -wave extraction, including high heart rates, high morphological QRST variability, and the presence of ventricular premature beats. Each set contains 30 5 min signals with different f -wave amplitudes. The database is used for the purpose of investigating the statistical association between different indices, designed for use with either real or simulated signals. Main results: Using the database, available at the PhysioNet repository of physiological signals, the performance indices unnormalized ventricular residue (uVR), designed for real signals, and the root mean square error, designed for simulated signals, were found to exhibit the strongest association, leading to the recommendation that uVR should be used when characterizing performance in real signals. Significance: The proposed database facilitates comparison of the performance of different f -wave extraction methods and makes it possible to express performance in terms of the error between simulated and extracted f -wave signals., This work was supported by project DPI2017-83952-C3 of the Spanish Ministry of Economy, Industry and Competitiveness, project SBPLY/17/180501/000411 of the Junta de Comunidades de Castilla-La Mancha, Grant 'Jose Castillejo' (CAS17/00436) from the Spanish Ministry of Education, Culture and Sport, Grant No. BEST/2017/028 from the Education, Research, Culture and Sports Department of Generalitat Valenciana, European Regional Development Fund, and Grant No. 03382/2016 from the Swedish Research Council.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Short-Term Bienenstock-Cooper-Munro Learning in Optoelectrically-Driven Flexible Halide Perovskite Single Crystal Memristors

  • Matchenya, Ivan
  • Khanas, Anton
  • Podgornyi, Roman
  • Shirkin, Daniil
  • Ekgardt, Alexey
  • Sizykh, Nikita
  • Anoshkin, Sergey
  • Krasnikov, Dmitry V.
  • Yulin, Alexei
  • Zhukov, Alexey
  • Nasibulin, Albert G.
  • Scheblykin, Ivan
  • Zenkevich, Andrei
  • Bisquert, Juan|||0000-0003-4987-4887
[EN] The transition to smart, wearable, and flexible optoelectronic devices that communicate with each other and perform neuromorphic computing at the edge, is a major goal in next-generation optoelectronics. These devices are expected to carry out their regular tasks while being supported by energy-efficient, in-memory computations. In this study, a lateral flexible device based on cesium lead tribromide perovskite single crystals integrated with single-walled carbon nanotube thin-film electrodes is presented. It is demonstrated that the device follows the Bienenstock-Cooper-Munro theory of synaptic modification under hybrid optoelectronic stimuli. This biorealistic response paves the way for the development of hybrid organic¿inorganic artificial visual systems., This work was supported by the Russian Science Foundation (project No. 23-72-00031(https://rscf.ru/prjcard_int?23-72-00031)). The authors gratefully acknowledged the Shared Research Facilities Center of Moscow Institute of Physics and Technology (SRF MIPT) for the access to the probe station and SEM. A.G.N. acknowledged the Russian Science Foundation (project No 22-13-00436) for the synthesis of carbon nanotubes. The authors thankfully acknowledged the ITMO-MIPT-Skoltech Clover Program. The authors acknowledged S. Baryshev and A. Averchenko for technical support. SEM images of ten samples (Figure S18, Supporting Information) were measured in the Advanced Imaging Core Facility (AICF) of the Skolkovo Institute of Science and Technology (Skoltech).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Role of factor XIII in ischemic stroke: a key molecule promoting thrombus stabilization and resistance to lysis

  • Marta-Enguita, Juan
  • Navarro-Oviedo, Manuel
  • Machado, Florencio J.D.
  • Bermejo, Rebeca
  • Aymerich, Nuria
  • Herrera, María
  • Zandio, Beatriz
  • Pagola, Jorge
  • Juega, Jesús
  • Marta-Moreno, Javier
  • Rodríguez, José Antonio
  • Páramo, José A.
  • Roncal Mancho, Carmen
  • Muñoz, Roberto
  • Orbe, Josune
Background: Active coagulation factor XIII (FXIII) catalyzing crosslinking of fibrin and other hemostatic factors plays a key role in clot stability and lysis. Objectives: To evaluate the effect of FXIII inhibition in a mouse model of ischemic stroke (IS) and the role of activated FXIII (FXIIIa) in clot formation and lysis in patients with IS. Methods: A ferric chloride IS murine model was performed before and after administration of a FXIIIa inhibitor (FXIIIinh). Thromboelastometry in human and mice blood was used to evaluate thrombus stiffness and lysis with FXIIIinh. FXIIIa-dependent fibrin crosslinking and lysis with fibrinolytic drugs (tissue plasminogen activator and tenecteplase) were studied on fibrin plates and on thrombi and clotted plasma of patients with IS. Finally, circulating and thrombus FXIIIa were measured in 85 patients with IS. Results: FXIIIinh administration before stroke induction reduced infarct size, α2-antiplasmin (α2AP) crosslinking, and local microthrombosis, improving motor coordination and fibrinolysis without intracranial bleeds (24 hours). Interestingly, FXIII blockade after stroke also reduced brain damage and neurologic deficit. Thromboelastometry in human/mice blood with FXIIIinh showed delayed clot formation, reduced clot firmness, and shortened tissue plasminogen activator lysis time. FXIIIa fibrin crosslinking increased fibrin density and lysis resistance, which increased further after α2AP addition. FXIIIinh enhanced ex vivo lysis in stroke thrombi and fibrin plates. In patients with IS, thrombus FXIII and α2AP were associated with inflammatory and hemostatic components, and plasma FXIIIa correlated with thrombus α2AP and fibrin. Conclusion: Our results suggest a key role of FXIIIa in thrombus stabilization, α2AP crosslinking, and lysis resistance, with a protective effect of FXIIIinh in an IS experimental model., This work was supported by ISCIII (PI19/00065-PI22/00436”), cofunded by ERDF, “A way to make Europe”; CIBERCV (CB16/11/00483); RICORS-ICTUS (RD21/0006/0008); the Spanish Society of Thrombosis and Hemostasis; and Virto S.A.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Transcriptomic profiling of thrombus-derived extracellular vesicles reveals PECAM-1 as a potential inflammatory marker for cardioembolic stroke patients

  • Machado, Florencio J.D.
  • Marta-Enguita, Juan
  • Herrera, María
  • Marta-Moreno, Javier
  • Páramo, José A.
  • Segura, Tomás
  • Serrano-Heras, Gemma
  • Hernández-Fernández, Francisco
  • Arias-Salazar, Lourdes
  • Yélamos-Sanz, Blanca
  • Zandio, Beatriz
  • Aymerich, Nuria
  • Muñoz, Roberto
  • Bermejo, Rebeca
  • Roncal Mancho, Carmen
  • Orbe, Josune
Accurate etiological diagnosis ensures appropriate secondary prevention of ischemic stroke (IS) patients. However, about 25–40% of IS cases remain of undetermined origin (referred to as ESUS if an unknown embolic source is suspected), highlighting the need to improve diagnostic precision. To identify potential biomarkers of IS etiologies, we analyzed the transcriptomic content of extracellular vesicles (EVs) from thrombi obtained after thrombectomy, including patients with cardioembolic (CE, n = 10), atherothrombotic (AT, n = 10) and ESUS (n = 10) IS (discovery cohort). mRNA levels of those differentially expressed genes in thrombus EVs were determined in microvascular brain endothelial cells after stimulation, revealing PECAM-1, as the most promising candidate. Next, PECAM-1 levels were determined in thrombi (n = 65) and serum samples (n = 95) of an independent validation cohort of IS patients, using immunohistochemistry and ELISA respectively. The transcriptome profiling and bioinformatics analysis revealed 1,514 gene transcripts in thrombus EVs, of which 114 were differentially expressed in AT vs CE etiologies. The genes upregulated in EVs from CE thrombi were enriched in pathways related to cell surface interactions at the vascular wall, leukocyte migration and neutrophil degranulation. Consistent with the increased PECAM-1 expression in thrombus EVs from CE vs AT etiologies, the endothelial expression of PECAM-1 increased after thrombin exposure and diminished upon atherogenic stimulation (oxLDL and TNFα). Moreover, thrombus expression of PECAM-1 was localized predominantly in platelet rich areas containing or surrounded by inflammatory cells and fibrin, and was higher in CE stroke thrombi. Serum levels of PECAM-1 were associated [OR (95%CI) 1.52 (1.14–2.03), p = 0.004] with the severity of stroke at Hospital admission. These findings collectively suggest that the transcriptional study of thrombus EVs may be useful to unravel the molecular pathways behind thrombus formation, and to explore local biological differences between IS etiologies. Specifically, PECAM-1, an adhesion molecule implicated in immuno-inflammatory processes, was increased in thrombi EVs and thrombi of patients with CE IS. Regarding the use of PECAM-1 as systemic biomarker, it did not discriminate IS etiologies, but was positively correlated with worse neurological outcome, suggesting a possible role of PECAM-1 in processes leading to brain injury post-IS., Red de Investigación Cooperativa Orientada a Resultados en Salud-Enfermedades Vasculares Cerebrales (RICORS-Ictus) RD21/0006/0008, RD24/0009/0028, and PI22/00436 financiado por el Instituto de Salud Carlos III, "Cofinanciado por la Unión Europea".
Addi. Archivo Digital para la Docencia y la Investigación
Publicación Artículo científico (JournalArticle)

Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes

  • Gómez Muñoz, Laia
  • Perna Barrull, David
  • Caroz Armayones, Josep M.
  • Murillo, Marta
  • Rodríguez Fernández, Silvia
  • Valls, Aina
  • Vázquez, Federico
  • Pérez Sánchez., Jacobo
  • Corripio Collado, Raquel
  • Castaño González, Luis Antonio
  • Bel, Joan
  • Vives Pi, Marta
[EN] The partial remission (PR) phase, a period experienced by most patients with type 1 diabetes (T1D) soon after diagnosis, is characterized by low insulin requirements and improved glycemic control. Given the great potential of this phase as a therapeutic window for immunotherapies because of its association with immunoregulatory mechanisms and beta-cell protection, our objective was to find peripheral immunological biomarkers for its better characterization, monitoring, and prediction. The longitudinal follow-up of 17 pediatric patients with new-onset T1D over one year revealed that, during the PR phase, remitter patients show increased percentages of effector memory (EM) T lymphocytes, terminally differentiated EM T lymphocytes, and neutrophils in comparison to non-remitter patients. On the contrary, remitter patients showed lower percentages of naive T lymphocytes, regulatory T cells (T-REG), and dendritic cells (DCs). After a year of follow-up, these patients also presented increased levels of regulatory B cells and transitional T1 B lymphocytes. On the other hand, although none of the analyzed cytokines (IL-2, IL-6, TGF-beta 1, IL-17A, and IL-10) could distinguish or predict remission, IL-17A was increased at T1D diagnosis in comparison to control subjects, and remitter patients tended to maintain lower levels of this cytokine than non-remitters. Therefore, these potential monitoring immunological biomarkers of PR support that this stage is governed by both metabolic and immunological factors and suggest immunoregulatory attempts during this phase. Furthermore, since the percentage of T-REG, monocytes, and DCs, and the total daily insulin dose at diagnosis were found to be predictors of the PR phase, we next created an index-based predictive model comprising those immune cell percentages that could potentially predict remission at T1D onset. Although our preliminary study needs further validation, these candidate biomarkers could be useful for the immunological characterization of the PR phase, the stratification of patients with better disease prognosis, and a more personalized therapeutic management., Funding for this study was provided by the Spanish Government (FIS PI18/00436) co-financed with the European Regional Development funds (FEDER), and by DiabetesCero Foundation. LGM is supported by the Generalitat de Catalunya (PERIS PIF-Salut Grant No. SLT017/20/000049). This work has been supported by positive discussion through Consolidated Research Group #2017 SGR 103, AGAUR, Generalitat de Catalunya.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Isolation and characterization of myogenic precursor cells from human cremaster muscle

  • Naldaiz-Gastesi, N.
  • Goicoechea, M.
  • Aragón, I.M.
  • Pérez-López, V.
  • Fuertes-Alvarez, S.
  • Herrera-Imbroda, B.
  • López de Munain, A.
  • de Luna-Diaz, R.
  • Baptista, P.M.
  • Fernández, M.A.
  • Lara, M.F.
  • Izeta, A.
Human myogenic precursor cells have been isolated and expanded from a number of skeletal muscles, but alternative donor biopsy sites must be sought after in diseases where muscle damage is widespread. Biopsy sites must be relatively accessible, and the biopsied muscle dispensable. Here, we aimed to histologically characterize the cremaster muscle with regard number of satellite cells and regenerative fibres, and to isolate and characterize human cremaster muscle-derived stem/precursor cells in adult male donors with the objective of characterizing this muscle as a novel source of myogenic precursor cells. Cremaster muscle biopsies (or adjacent non-muscle tissue for negative controls; N = 19) were taken from male patients undergoing routine surgery for urogenital pathology. Myosphere cultures were derived and tested for their in vitro and in vivo myogenic differentiation and muscle regeneration capacities. Cremaster-derived myogenic precursor cells were maintained by myosphere culture and efficiently differentiated to myotubes in adhesion culture. Upon transplantation to an immunocompromised mouse model of cardiotoxin-induced acute muscle damage, human cremaster-derived myogenic precursor cells survived to the transplants and contributed to muscle regeneration. These precursors are a good candidate for cell therapy approaches of skeletal muscle. Due to their location and developmental origin, we propose that they might be best suited for regeneration of the rhabdosphincter in patients undergoing stress urinary incontinence after radical prostatectomy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential

  • Rodríguez Fernández, Silvia
  • Murillo-Vallés, Marta|||0000-0002-3208-2982
  • Villalba Felipe, Adrián|||0000-0003-3148-5453
  • Perna-Barrull, David|||0000-0003-2079-818X
  • Cano-Sarabia, Mary|||0000-0003-4254-8157
  • Gómez Muñoz, Laia|||0000-0001-9640-6213
  • Aguilera, Eva|||0000-0002-0164-4006
  • Maspoch, Daniel|||0000-0003-1325-9161
  • Vázquez, Federico|||0000-0001-6493-2374
  • Bel, Joan|||0000-0002-3577-6322
  • Vives Pi, Marta|||0000-0003-3735-0779
Type 1 diabetes (T1D) is prompted by defective immunological tolerance, an event in which dendritic cells (DCs) are crucial as immune response orchestrators. In fact, they contribute to maintaining tolerance to self-antigens, but they can also prompt an immunogenic response against them, leading to autoimmunity. Countless factors can potentially impact on the proper functionality of the DCs, which range from altered subset distribution, impaired phagocytic function to abnormal gene expression. Moreover, in T1D, metabolic dysregulation could impair DC functions as well. Indeed, since T1D clinical course is likely to be more aggressive in children and adolescents and entails severe dysglycemia, the aim of this study was to analyze circulating DCs subpopulations in pediatric T1D at different stages, as well as to characterize their phagocytosis ability and tolerance induction potential. Thus, pediatric patients newly diagnosed with T1D, with established disease and control subjects were recruited. Firstly, DCs subsets from peripheral blood were found quantitatively altered during the first year of disease, but recovered in the second year of progression. Secondly, to study the tolerogenic functionality of DCs, liposomes with phosphatidylserine (PS) were designed to mimic apoptotic beta cells, which are able to induce tolerance, as previously demonstrated by our group in DCs from adult patients with T1D. In this study, monocyte-derived DCs from pediatric patients with T1D and control subjects were assessed in terms of PS-liposomes capture kinetics, and transcriptional and phenotypic changes. DCs from pediatric patients with T1D were found to phagocyte PS-liposomes more slowly and less efficiently than DCs from control subjects, inversely correlating with disease evolution. Nonetheless, the transcription of PS receptors and immunoregulatory genes, cytokine profile, and membrane expression of immunological markers in DCs was consistent with tolerogenic potential after PS-liposomes phagocytosis. In conclusion, T1D progression in childhood entails altered peripheral blood DCs subsets, as well as impaired DCs phagocytosis, although tolerance induction could still function optimally. Therefore, this study provides useful data for patient follow-up and stratification in immunotherapy clinical trials.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Partial remission and early stages of pediatric type 1 diabetes display immunoregulatory changes. A pilot study

  • Villalba Felipe, Adrián|||0000-0003-3148-5453
  • Fonolleda, Mireia
  • Murillo-Vallés, Marta|||0000-0002-3208-2982
  • Rodríguez-Fernández, Silvia|||0000-0001-8429-4293
  • Ampudia Carrasco, Rosa María|||0000-0002-0734-0433
  • Perna-Barrull, David|||0000-0003-2079-818X
  • Raina, María Belén
  • Quirant, Bibiana|||0000-0002-3875-8074
  • Planas, Raquel
  • Teniente Serra, Aina|||0000-0003-3440-804X
  • Bel, Joan|||0000-0002-3577-6322
  • Vives Pi, Marta|||0000-0003-3735-0779
Type 1 diabetes (T1D) is a chronic metabolic disease of unknown etiology that results from β-cell destruction. The onset of the disease, which arises after a long asymptomatic period of autoimmune attack, may be followed by a relapsing and remitting progression, a phenomenon that is most evident during the partial remission phase (PR). This stage lasts for a few months, shows minor requirements of exogenous insulin and could be explained by a recovery of immunological tolerance. This study aims to identify new biomarkers at early stages of pediatric T1D that reflect immunoregulatory changes. To that end, pediatric patients with T1D (n = 52) and age-related control subjects (n = 30) were recruited. Immune response-related molecules and lymphocyte subsets were determined starting at T1D onset and until the second year of progression. Results showed that circulating TGF-β levels decreased during PR, and that betatrophin concentration was increased in all the considered stages without differing among studied checkpoints. Moreover, an increase of regulatory T, B and NK subsets was found during T1D progression, probably reflecting an attempt to restore self-tolerance. By contrast, a reduction in monocyte levels was observed at the early stages of diabetes. The results reveal significant changes in immunological parameters during the different early stages of T1D in children, which could ultimately serve as potential biomarkers to characterize the progression of T1D.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes

  • Gómez Muñoz, Laia|||0000-0001-9640-6213
  • Perna-Barrull, David|||0000-0003-2079-818X
  • Villalba Felipe, Adrián|||0000-0003-3148-5453
  • Rodríguez-Fernández, Silvia|||0000-0001-8429-4293
  • Ampudia Carrasco, Rosa María|||0000-0002-0734-0433
  • Teniente Serra, Aina|||0000-0003-3440-804X
  • Vázquez, Federico|||0000-0001-6493-2374
  • Murillo-Vallés, Marta|||0000-0002-3208-2982
  • Pérez Sánchez, Jacobo|||0000-0003-0574-3594
  • Corripio, Raquel|||0000-0003-3344-8269
  • Bel, Joan|||0000-0002-3577-6322
  • Vives Pi, Marta|||0000-0003-3735-0779
Type 1 diabetes (T1D) is a chronic metabolic disease characterized by the autoimmune destruction of β-cells in the pancreatic islets. T1D is preceded by islet-specific inflammation led by several immune cells. Among them, natural killer (NK) cells are emerging as important players in T1D development. Human NK cells are characterized by CD56 and CD16 expression, which allows classifying NK cells into four subsets: 1) CD56 dim CD16 + or effector NK cells (NK); 2) CD56 bright CD16 - or regulatory NK cells (NK); 3) intermediate CD56 bright CD16 + NK cells; and 4) CD56 dim CD16 - NK cells, whose function is not well determined. Since many studies have shown that T1D progression is associated with changes in various immune cell types, we hypothesize that the kinetics of NK cell subsets in the blood could correlate with different stages of T1D. To that aim, pediatric patients newly diagnosed with T1D were recruited, and peripheral NK cell subsets were analyzed by flow cytometry at several disease checkpoints: disease onset, partial remission (PR), 8 months (for non-remitters), and 12 months of progression. Our results showed that total NK cells and their four subsets are altered at the early stages of T1D. A decrease in the counts and percentage of total NK cells and NK cells at the different disease stages was found when compared to controls. These results suggest the extravasation of these cells into the islets at disease onset, which is maintained throughout the follow-up. By contrast, NK cells increased during the early stages after T1D onset, and both intermediate NK cells and CD56 dim CD16 - NK cells diminished at the PR stage, which might reflect the immunoregulatory attempts and could be candidate biomarkers for this stage. Also, CD56 dim CD16 - NK cells increased during T1D progression. Finally, changes in CD16 expression were identified in the different T1D stages, highlighting a CD16 expression reduction in total NK cells and NK cells 1 year after diagnosis. That may reflect a state of exhaustion after multiple cell-to-cell interactions. Altogether, our preliminary data provide a longitudinal picture of peripheral NK cell subpopulations during the different T1D stages, which could be potential candidate biomarkers indicators of disease progression.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes

  • Gómez Muñoz, Laia|||0000-0001-9640-6213
  • Perna-Barrull, David|||0000-0003-2079-818X
  • Caroz-Armayones, Josep M.
  • Murillo-Vallés, Marta|||0000-0002-3208-2982
  • Rodríguez-Fernández, Silvia|||0000-0001-8429-4293
  • Valls, Aina|||0000-0002-0751-5029
  • Vázquez, Federico|||0000-0001-6493-2374
  • Pérez Sánchez, Jacobo|||0000-0003-0574-3594
  • Corripio, Raquel|||0000-0003-3344-8269
  • Castaño, Luis|||0000-0003-0437-9401
  • Bel, Joan|||0000-0002-3577-6322
  • Vives Pi, Marta|||0000-0003-3735-0779
The partial remission (PR) phase, a period experienced by most patients with type 1 diabetes (T1D) soon after diagnosis, is characterized by low insulin requirements and improved glycemic control. Given the great potential of this phase as a therapeutic window for immunotherapies because of its association with immunoregulatory mechanisms and β-cell protection, our objective was to find peripheral immunological biomarkers for its better characterization, monitoring, and prediction. The longitudinal follow-up of 17 pediatric patients with new-onset T1D over one year revealed that, during the PR phase, remitter patients show increased percentages of effector memory (EM) T lymphocytes, terminally differentiated EM T lymphocytes, and neutrophils in comparison to non-remitter patients. On the contrary, remitter patients showed lower percentages of naïve T lymphocytes, regulatory T cells (T), and dendritic cells (DCs). After a year of follow-up, these patients also presented increased levels of regulatory B cells and transitional T1 B lymphocytes. On the other hand, although none of the analyzed cytokines (IL-2, IL-6, TGF-β1, IL-17A, and IL-10) could distinguish or predict remission, IL-17A was increased at T1D diagnosis in comparison to control subjects, and remitter patients tended to maintain lower levels of this cytokine than non-remitters. Therefore, these potential monitoring immunological biomarkers of PR support that this stage is governed by both metabolic and immunological factors and suggest immunoregulatory attempts during this phase. Furthermore, since the percentage of T, monocytes, and DCs, and the total daily insulin dose at diagnosis were found to be predictors of the PR phase, we next created an index-based predictive model comprising those immune cell percentages that could potentially predict remission at T1D onset. Although our preliminary study needs further validation, these candidate biomarkers could be useful for the immunological characterization of the PR phase, the stratification of patients with better disease prognosis, and a more personalized therapeutic management.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Gene Expression Analysis of the Bone Marrow Microenvironment Reveals Distinct Immunotypes in Smoldering Multiple Myeloma Associated to Progression to Symptomatic Disease

  • Isola, Ignacio
  • Brasó-Maristany, Fara|||0000-0001-5440-9643
  • Moreno, David F.
  • Mena, Mari Pau
  • Oliver-Caldés, Aina|||0000-0002-7921-5420
  • Paré Brunet, Laia
  • Rodríguez Lobato, Luis Gerardo|||0000-0001-5694-0921
  • Martín-Antonio, B|||0000-0003-0612-2693
  • Cibeira, María Teresa|||0000-0002-4036-754X
  • Bladé Creixenti, Juan|||0000-0002-4563-3405
  • Rosiñol, Laura|||0000-0002-2534-9239
  • Prat, Aleix|||0000-0003-2377-540X
  • Lozano, Ester|||0000-0002-6307-9807
  • Fernández de Larrea, Carlos|||0000-0003-4930-9255
Background: We previously reported algorithms based on clinical parameters and plasma cell characteristics to identify patients with smoldering multiple myeloma (SMM) with higher risk of progressing who could benefit from early treatment. In this work, we analyzed differences in the immune bone marrow (BM) microenvironment in SMM to better understand the role of immune surveillance in disease progression and to identify immune biomarkers associated to higher risk of progression. Methods: Gene expression analysis of BM cells from 28 patients with SMM, 22 patients with monoclonal gammopathy of undetermined significance (MGUS) and 22 patients with symptomatic MM was performed by using Nanostring Technology. Results: BM cells in SMM compared to both MGUS and symptomatic MM showed upregulation of genes encoding for key molecules in cytotoxicity. However, some of these cytotoxic molecules positively correlated with inhibitory immune checkpoints, which may impair the effector function of BM cytotoxic cells. Analysis of 28 patients with SMM revealed 4 distinct clusters based on immune composition and activation markers. Patients in cluster 2 showed a significant increase in expression of cytotoxic molecules but also inhibitory immune checkpoints compared to cluster 3, suggesting the presence of cytotoxic cells with an exhausted phenotype. Accordingly, patients in cluster 3 had a significantly longer progression free survival. Finally, individual gene expression analysis showed that higher expression of TNF superfamily members (TNF, TNFAIP3, TNFRSF14) was associated with shorter progression free survival. Conclusions: Our results suggest that exhausted cytotoxic cells are associated to high-risk patients with SMM. Biomarkers overexpressed in patients with this immune gene profile in combination with clinical parameters and PC characterization may be useful to identify SMM patients with higher risk of progression.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes, miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion

  • Gómez Muñoz, Laia|||0000-0001-9640-6213
  • Perna-Barrull, David|||0000-0003-2079-818X
  • Murillo-Vallés, Marta|||0000-0002-3208-2982
  • Armengol, Maria Pilar
  • Alcalde-Herraiz, Marta|||0009-0002-4405-1814
  • Català, Martí|||0000-0003-3308-9905
  • Rodríguez-Fernández, Silvia|||0000-0001-8429-4293
  • Sunye, Sergi
  • Valls, Aina|||0000-0002-0751-5029
  • Pérez Sánchez, Jacobo|||0000-0003-0574-3594
  • Corripio, Raquel|||0000-0003-3344-8269
  • Vives Pi, Marta|||0000-0003-3735-0779
The partial remission (PR) phase of type 1 diabetes (T1D) is an underexplored period characterized by endogenous insulin production and downmodulated autoimmunity. To comprehend the mechanisms behind this transitory phase and develop precision medicine strategies, biomarker discovery and patient stratification are unmet needs. MicroRNAs (miRNAs) are small RNA molecules that negatively regulate gene expression and modulate several biological processes, functioning as biomarkers for many diseases. Here, we identify and validate a unique miRNA signature during PR in pediatric patients with T1D by employing small RNA sequencing and RT-qPCR. These miRNAs were mainly related to the immune system, metabolism, stress, and apoptosis pathways. The implication in autoimmunity of the most dysregulated miRNA, miR-30d-5p, was evaluated in vivo in the non-obese diabetic mouse. MiR-30d-5p inhibition resulted in increased regulatory T cell percentages in the pancreatic lymph nodes together with a higher expression of CD200. In the spleen, a decrease in PD-1 + T lymphocytes and reduced PDCD1 expression were observed. Moreover, miR-30d-5p inhibition led to an increased islet leukocytic infiltrate and changes in both effector and memory T lymphocytes. In conclusion, the miRNA signature found during PR shows new putative biomarkers and highlights the immunomodulatory role of miR-30d-5p, elucidating the processes driving this phase.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Corrigendum, NK cell subsets changes in partial remission and early stages of pediatric type 1 diabetes(Front Immunol., 11, (611522), 10.3389/fimmu.2020.611522)

  • Gómez Muñoz, Laia|||0000-0001-9640-6213
  • Perna-Barrull, David|||0000-0003-2079-818X
  • Villalba Felipe, Adrián|||0000-0003-3148-5453
  • Rodríguez-Fernández, Silvia|||0000-0001-8429-4293
  • Ampudia Carrasco, Rosa María|||0000-0002-0734-0433
  • Teniente Serra, Aina|||0000-0003-3440-804X
  • Vázquez, Federico|||0000-0001-6493-2374
  • Murillo-Vallés, Marta|||0000-0002-3208-2982
  • Pérez Sánchez, Jacobo|||0000-0003-0574-3594
  • Corripio, Raquel|||0000-0003-3344-8269
  • Bel, Joan|||0000-0002-3577-6322
  • Vives Pi, Marta|||0000-0003-3735-0779
In the published article, there was an error in the Funding statement. The Funding statement was displayed as "This work has been funded by the Spanish Government (FIS PI18/00436) co-financed with the European Regional Development funds (FEDER), and by DiabetesCero Foundation.". The correct Funding statement appears below. This study has been funded by Instituto de Salud Carlos III through the project PI18/00436 (Co-funded by European Regional Development Fund 'A way to make Europe'), and by DiabetesCero Foundation. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Corrigendum, Candidate biomarkers for the prediction and monitoring of partial remission in pediatric type 1 diabetes(Front. Immunol., (2022), 13, (825426), 10.3389/fimmu.2022.825426)

  • Gómez Muñoz, Laia|||0000-0001-9640-6213
  • Perna-Barrull, David|||0000-0003-2079-818X
  • Caroz-Armayones, Josep M.
  • Murillo-Vallés, Marta|||0000-0002-3208-2982
  • Rodríguez-Fernández, Silvia|||0000-0001-8429-4293
  • Valls, Aina|||0000-0002-0751-5029
  • Vázquez, Federico|||0000-0001-6493-2374
  • Pérez Sánchez, Jacobo|||0000-0003-0574-3594
  • Corripio, Raquel|||0000-0003-3344-8269
  • Castaño, Luis|||0000-0003-0437-9401
  • Bel, Joan|||0000-0002-3577-6322
  • Vives Pi, Marta|||0000-0003-3735-0779
In the published article, there was an error in the Funding statement. One of the funding bodies was incorrectly listed as "the Spanish Government (FIS PI18/00436)". The correct Funding statement appears below.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Screening of alternative nitrogen sources for sophorolipid production through submerged fermentation using Starmerella bombicola

  • Eras Muñoz, Estefanía Nathaly|||0000-0002-7085-4576
  • Wongsirichot, Phavit|||0000-0001-7635-9392
  • Ingham, Benjamin|||0000-0002-2058-5531
  • Winterburn, James|||0000-0002-6608-9883
  • Gea, Teresa|||0000-0003-2523-4797
  • Font, Xavier|||0000-0003-4981-7436
To explore a sustainable sophorolipid production, several hydrolysates from agricultural byproducts, such as wheat feed, rapeseed meal, coconut waste and palm waste were used as nitrogen sources. The four hydrolysates overperformed the controls after 168 h of fermentation using Starmerella bombicola ATCC 22214. Wheat feed and coconut waste hydrolysates were the most promising feedstocks presenting a linear relationship between yeast growth and diacetylated lactonic C18:1 production at total nitrogen concentrations below 1.5 g/L (R = 0.90 and 0.83, respectively). At 0.31 g/L total nitrogen, wheat feed hydrolysate achieved the highest production, yielding 72.20 ± 1.53 g/L of sophorolipid crude extract and 60.05 ± 0.56 g/L of diacetylated lactonic C18:1 at shake flask scale with productivities of 0.43 and 0.36 g/L/h, respectively. Results were confirmed in a 2-L bioreactor increasing 15 % diacetylated lactonic C18:1 production. Moreover, wheat feed hydrolysate supplemented only with a hydrophobic carbon source was able to produce mainly diacetylated lactonic C18:1 congener (88.5 % wt.), suggesting that the composition of the hydrolysate significantly influences the congeners profile. Overall, this study provides valuable insights into agricultural byproduct hydrolysates as potential nitrogen feedstocks for sophorolipid production and their further application on industrial biotechnology.